Dirk Hendriks

3.3k total citations
96 papers, 2.5k citations indexed

About

Dirk Hendriks is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Dirk Hendriks has authored 96 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 36 papers in Molecular Biology and 26 papers in Hematology. Recurrent topics in Dirk Hendriks's work include Peptidase Inhibition and Analysis (43 papers), Blood Coagulation and Thrombosis Mechanisms (23 papers) and Neuropeptides and Animal Physiology (19 papers). Dirk Hendriks is often cited by papers focused on Peptidase Inhibition and Analysis (43 papers), Blood Coagulation and Thrombosis Mechanisms (23 papers) and Neuropeptides and Animal Physiology (19 papers). Dirk Hendriks collaborates with scholars based in Belgium, Sweden and Israel. Dirk Hendriks's co-authors include Simon Scharpé, Filip Goossens, Ingrid De Meester, Greet Vanhoof, M. van Sande, Judith Leurs, Johan Willemse, K. Schatteman, Simon Scharpé and Hugo Neels and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Biochemistry and The FASEB Journal.

In The Last Decade

Dirk Hendriks

96 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dirk Hendriks Belgium 27 938 899 753 408 360 96 2.5k
Hearn Jay Cho United States 27 1.1k 1.2× 1.5k 1.7× 971 1.3× 146 0.4× 170 0.5× 140 4.0k
Peter Presek Germany 25 476 0.5× 773 0.9× 164 0.2× 181 0.4× 242 0.7× 49 2.0k
J M Wood Switzerland 25 225 0.2× 1.7k 1.9× 577 0.8× 453 1.1× 181 0.5× 49 3.1k
Chunhua Song United States 33 514 0.5× 1.9k 2.1× 273 0.4× 263 0.6× 111 0.3× 125 3.4k
Lajos Gera United States 29 258 0.3× 1.3k 1.4× 528 0.7× 142 0.3× 299 0.8× 106 2.8k
Ruth F. Nutt United States 28 274 0.3× 1.8k 2.1× 644 0.9× 87 0.2× 253 0.7× 59 3.0k
David M. Koeller United States 30 565 0.6× 2.9k 3.3× 506 0.7× 155 0.4× 216 0.6× 66 4.4k
Jacquelynn J. Cook United States 30 703 0.7× 826 0.9× 238 0.3× 161 0.4× 179 0.5× 75 2.4k
Gudmar Lönnerholm Sweden 33 753 0.8× 1.4k 1.5× 335 0.4× 116 0.3× 65 0.2× 119 3.0k
Shin Hayashi Japan 34 469 0.5× 1.8k 2.0× 738 1.0× 434 1.1× 222 0.6× 113 3.9k

Countries citing papers authored by Dirk Hendriks

Since Specialization
Citations

This map shows the geographic impact of Dirk Hendriks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Hendriks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Hendriks more than expected).

Fields of papers citing papers by Dirk Hendriks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Hendriks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Hendriks. The network helps show where Dirk Hendriks may publish in the future.

Co-authorship network of co-authors of Dirk Hendriks

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Hendriks. A scholar is included among the top collaborators of Dirk Hendriks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Hendriks. Dirk Hendriks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cardona, Pere, et al.. (2021). Carboxypeptidase U (TAFIa) Is Rapidly Activated and Deactivated Following Thrombolysis and Thrombectomy in Stroke Patients. Translational Stroke Research. 13(6). 959–969. 1 indexed citations
2.
3.
Hendriks, Dirk, et al.. (2021). Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery?. International Journal of Molecular Sciences. 22(2). 883–883. 17 indexed citations
4.
Boisseau, William, Lucas Di Meglio, Stéphane Loyau, et al.. (2020). Selective inhibition of carboxypeptidase U may reduce microvascular thrombosis in rat experimental stroke. Journal of Thrombosis and Haemostasis. 18(12). 3325–3335. 6 indexed citations
5.
Westbury, Sarah K., Claire S. Whyte, Jonathan Stephens, et al.. (2020). A new pedigree with thrombomodulin‐associated coagulopathy in which delayed fibrinolysis is partially attenuated by co‐inherited TAFI deficiency. Journal of Thrombosis and Haemostasis. 18(9). 2209–2214. 21 indexed citations
6.
Brouns, Raf, S. Engelborghs, M. Ieven, et al.. (2017). Procarboxypeptidase U (proCPU, TAFI, proCPB2) in cerebrospinal fluid during ischemic stroke is associated with stroke progression, outcome and blood–brain barrier dysfunction. Journal of Thrombosis and Haemostasis. 16(2). 342–348. 16 indexed citations
7.
Baerts, Lesley, Raf Brouns, Robert Verkerk, et al.. (2016). Acute Ischemic Stroke Severity, Progression, and Outcome Relate to Changes in Dipeptidyl Peptidase IV and Fibroblast Activation Protein Activity. Translational Stroke Research. 8(2). 157–164. 19 indexed citations
8.
Foley, Jonathan H., et al.. (2015). Evaluation of and recommendation for the nomenclature of the CPB2 gene product (also known as TAFI and proCPU): communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 13(12). 2277–2278. 12 indexed citations
9.
Bosmans, Johan, et al.. (2015). Plasma levels of carboxypeptidase U (CPU, CPB2 or TAFIa) are elevated in patients with acute myocardial infarction. Journal of Thrombosis and Haemostasis. 13(12). 2227–2232. 15 indexed citations
10.
Brouns, Raf, Evelien Heylen, Johan Willemse, et al.. (2009). The decrease in procarboxypeptidase U (TAFI) concentration in acute ischemic stroke correlates with stroke severity, evolution and outcome. Journal of Thrombosis and Haemostasis. 8(1). 75–80. 34 indexed citations
11.
Deiteren, Kathleen, Dirk Hendriks, Simon Scharpé, & Anne‐Marie Lambeir. (2008). Carboxypeptidase M: Multiple alliances and unknown partners. Clinica Chimica Acta. 399(1-2). 24–39. 41 indexed citations
12.
Willemse, Johan, Magnus Polla, & Dirk Hendriks. (2006). The intrinsic enzymatic activity of plasma procarboxypeptidase U (TAFI) can interfere with plasma carboxypeptidase N assays. Analytical Biochemistry. 356(1). 157–159. 16 indexed citations
13.
14.
Willemse, Johan & Dirk Hendriks. (2006). A rapid and sensitive assay for the quantitation of carboxypeptidase N, an important regulator of inflammation. Clinica Chimica Acta. 371(1-2). 124–129. 3 indexed citations
15.
Maes, Michaël, E. Bosmans, Simon Scharpé, et al.. (1997). Components of biological variation in serum soluble transferrin receptor: relationships to serum iron, transferrin and ferritin concentrations, and immune and haematological variables. Scandinavian Journal of Clinical and Laboratory Investigation. 57(1). 31–41. 40 indexed citations
16.
Wauters, J., K. Schatteman, Dirk Hendriks, et al.. (1996). The Gene for Human Carboxypeptidase U (CPU)— A Proposed Novel Regulator of Plasminogen Activation— Maps to 13q14.11. Genomics. 38(3). 454–455. 35 indexed citations
17.
Vanhoof, Greet, Ingrid De Meester, Filip Goossens, et al.. (1992). Kininase activity in human platelets: Cleavage of the Arg1-Pro2 bond of bradykinin by aminopeptidase P. Biochemical Pharmacology. 44(3). 479–487. 29 indexed citations
18.
Hendriks, Dirk, et al.. (1992). Human Serum Carboxypeptidase U: A New Kininase ?. Birkhäuser Basel eBooks. 38 ( Pt 1). 407–413. 6 indexed citations
19.
Hendriks, Dirk, et al.. (1990). Purification and characterization of a new arginine carboxypeptidase in human serum. Biochimica et Biophysica Acta (BBA) - General Subjects. 1034(1). 86–92. 93 indexed citations
20.
Hendriks, Dirk, et al.. (1987). Carboxypeptidase N: Colorimetric assay using a new substrate. Analytical Biochemistry. 164(1). 90–95. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hearn Jay Cho Breakdown of academic impact, for papers by Peter Presek Breakdown of academic impact, for papers by J M Wood Breakdown of academic impact, for papers by Chunhua Song Breakdown of academic impact, for papers by Lajos Gera Breakdown of academic impact, for papers by Ruth F. Nutt Breakdown of academic impact, for papers by David M. Koeller Breakdown of academic impact, for papers by Jacquelynn J. Cook Breakdown of academic impact, for papers by Gudmar Lönnerholm Breakdown of academic impact, for papers by Shin Hayashi
Rankless by CCL
2026